IBDEI0LB ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28838,1,3,0)
 ;;=3^078.10
 ;;^UTILITY(U,$J,358.3,28838,1,4,0)
 ;;=4^Genital Warts
 ;;^UTILITY(U,$J,358.3,28838,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,28839,0)
 ;;=625.3^^161^1805^18
 ;;^UTILITY(U,$J,358.3,28839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28839,1,3,0)
 ;;=3^625.3
 ;;^UTILITY(U,$J,358.3,28839,1,4,0)
 ;;=4^Dysmenorrhea
 ;;^UTILITY(U,$J,358.3,28839,2)
 ;;=^37592
 ;;^UTILITY(U,$J,358.3,28840,0)
 ;;=625.0^^161^1805^19
 ;;^UTILITY(U,$J,358.3,28840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28840,1,3,0)
 ;;=3^625.0
 ;;^UTILITY(U,$J,358.3,28840,1,4,0)
 ;;=4^Dyspareunia
 ;;^UTILITY(U,$J,358.3,28840,2)
 ;;=^37604
 ;;^UTILITY(U,$J,358.3,28841,0)
 ;;=788.1^^161^1805^23
 ;;^UTILITY(U,$J,358.3,28841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28841,1,3,0)
 ;;=3^788.1
 ;;^UTILITY(U,$J,358.3,28841,1,4,0)
 ;;=4^Dysuria
 ;;^UTILITY(U,$J,358.3,28841,2)
 ;;=^37716
 ;;^UTILITY(U,$J,358.3,28842,0)
 ;;=789.30^^161^1805^34
 ;;^UTILITY(U,$J,358.3,28842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28842,1,3,0)
 ;;=3^789.30
 ;;^UTILITY(U,$J,358.3,28842,1,4,0)
 ;;=4^Pelvic Abdominal Mass
 ;;^UTILITY(U,$J,358.3,28842,2)
 ;;=^917
 ;;^UTILITY(U,$J,358.3,28843,0)
 ;;=614.9^^161^1805^35
 ;;^UTILITY(U,$J,358.3,28843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28843,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,28843,1,4,0)
 ;;=4^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,28843,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,28844,0)
 ;;=599.0^^161^1805^45
 ;;^UTILITY(U,$J,358.3,28844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28844,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,28844,1,4,0)
 ;;=4^Urin Tract Infection Nos
 ;;^UTILITY(U,$J,358.3,28844,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,28845,0)
 ;;=218.9^^161^1805^46
 ;;^UTILITY(U,$J,358.3,28845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28845,1,3,0)
 ;;=3^218.9
 ;;^UTILITY(U,$J,358.3,28845,1,4,0)
 ;;=4^Uterine Fibroids
 ;;^UTILITY(U,$J,358.3,28845,2)
 ;;=^68944
 ;;^UTILITY(U,$J,358.3,28846,0)
 ;;=618.1^^161^1805^47
 ;;^UTILITY(U,$J,358.3,28846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28846,1,3,0)
 ;;=3^618.1
 ;;^UTILITY(U,$J,358.3,28846,1,4,0)
 ;;=4^Uterine Prolapse
 ;;^UTILITY(U,$J,358.3,28846,2)
 ;;=^124773
 ;;^UTILITY(U,$J,358.3,28847,0)
 ;;=112.1^^161^1805^48
 ;;^UTILITY(U,$J,358.3,28847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28847,1,3,0)
 ;;=3^112.1
 ;;^UTILITY(U,$J,358.3,28847,1,4,0)
 ;;=4^Vaginitis, Candidal
 ;;^UTILITY(U,$J,358.3,28847,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,28848,0)
 ;;=099.53^^161^1805^49
 ;;^UTILITY(U,$J,358.3,28848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28848,1,3,0)
 ;;=3^099.53
 ;;^UTILITY(U,$J,358.3,28848,1,4,0)
 ;;=4^Vaginitis, Chlamydial
 ;;^UTILITY(U,$J,358.3,28848,2)
 ;;=^293988
 ;;^UTILITY(U,$J,358.3,28849,0)
 ;;=131.01^^161^1805^50
 ;;^UTILITY(U,$J,358.3,28849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28849,1,3,0)
 ;;=3^131.01
 ;;^UTILITY(U,$J,358.3,28849,1,4,0)
 ;;=4^Vaginitis, Trichonomal
 ;;^UTILITY(U,$J,358.3,28849,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,28850,0)
 ;;=592.0^^161^1805^30
 ;;^UTILITY(U,$J,358.3,28850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28850,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,28850,1,4,0)
 ;;=4^Kidney Stones
 ;;^UTILITY(U,$J,358.3,28850,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,28851,0)
 ;;=627.2^^161^1805^44
 ;;^UTILITY(U,$J,358.3,28851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28851,1,3,0)
 ;;=3^627.2
 ;;^UTILITY(U,$J,358.3,28851,1,4,0)
 ;;=4^Symptomatic Menopause
 ;;^UTILITY(U,$J,358.3,28851,2)
 ;;=^328735
 ;;^UTILITY(U,$J,358.3,28852,0)
 ;;=622.10^^161^1805^20
 ;;^UTILITY(U,$J,358.3,28852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28852,1,3,0)
 ;;=3^622.10
 ;;^UTILITY(U,$J,358.3,28852,1,4,0)
 ;;=4^Dysplasia of Cervix
 ;;^UTILITY(U,$J,358.3,28852,2)
 ;;=^331546
 ;;^UTILITY(U,$J,358.3,28853,0)
 ;;=622.11^^161^1805^21
 ;;^UTILITY(U,$J,358.3,28853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28853,1,3,0)
 ;;=3^622.11
 ;;^UTILITY(U,$J,358.3,28853,1,4,0)
 ;;=4^Dysplasia of Cervix, Mild
 ;;^UTILITY(U,$J,358.3,28853,2)
 ;;=^331547
 ;;^UTILITY(U,$J,358.3,28854,0)
 ;;=622.12^^161^1805^22
 ;;^UTILITY(U,$J,358.3,28854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28854,1,3,0)
 ;;=3^622.12
 ;;^UTILITY(U,$J,358.3,28854,1,4,0)
 ;;=4^Dysplasia of Cervix, Moderate
 ;;^UTILITY(U,$J,358.3,28854,2)
 ;;=^331548
 ;;^UTILITY(U,$J,358.3,28855,0)
 ;;=V72.40^^161^1805^38
 ;;^UTILITY(U,$J,358.3,28855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28855,1,3,0)
 ;;=3^V72.40
 ;;^UTILITY(U,$J,358.3,28855,1,4,0)
 ;;=4^Pregnancy Exam/Test
 ;;^UTILITY(U,$J,358.3,28855,2)
 ;;=^331589
 ;;^UTILITY(U,$J,358.3,28856,0)
 ;;=V72.31^^161^1805^27
 ;;^UTILITY(U,$J,358.3,28856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28856,1,3,0)
 ;;=3^V72.31
 ;;^UTILITY(U,$J,358.3,28856,1,4,0)
 ;;=4^Gyn Examination, Routine
 ;;^UTILITY(U,$J,358.3,28856,2)
 ;;=^331587
 ;;^UTILITY(U,$J,358.3,28857,0)
 ;;=V67.01^^161^1805^32
 ;;^UTILITY(U,$J,358.3,28857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28857,1,3,0)
 ;;=3^V67.01
 ;;^UTILITY(U,$J,358.3,28857,1,4,0)
 ;;=4^Pap Smear Following Surgery
 ;;^UTILITY(U,$J,358.3,28857,2)
 ;;=^322078
 ;;^UTILITY(U,$J,358.3,28858,0)
 ;;=627.4^^161^1805^10
 ;;^UTILITY(U,$J,358.3,28858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28858,1,3,0)
 ;;=3^627.4
 ;;^UTILITY(U,$J,358.3,28858,1,4,0)
 ;;=4^Artificial Menopause-Symptomatic
 ;;^UTILITY(U,$J,358.3,28858,2)
 ;;=^328736
 ;;^UTILITY(U,$J,358.3,28859,0)
 ;;=793.80^^161^1805^1
 ;;^UTILITY(U,$J,358.3,28859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28859,1,3,0)
 ;;=3^793.80
 ;;^UTILITY(U,$J,358.3,28859,1,4,0)
 ;;=4^Abnormal Mammogram
 ;;^UTILITY(U,$J,358.3,28859,2)
 ;;=^323613
 ;;^UTILITY(U,$J,358.3,28860,0)
 ;;=V76.47^^161^1805^39
 ;;^UTILITY(U,$J,358.3,28860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28860,1,3,0)
 ;;=3^V76.47
 ;;^UTILITY(U,$J,358.3,28860,1,4,0)
 ;;=4^Special Screening for vaginal Malignant Neoplasms
 ;;^UTILITY(U,$J,358.3,28860,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,28861,0)
 ;;=V45.77^^161^1805^7
 ;;^UTILITY(U,$J,358.3,28861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28861,1,3,0)
 ;;=3^V45.77
 ;;^UTILITY(U,$J,358.3,28861,1,4,0)
 ;;=4^Acquired Absence of Uterus
 ;;^UTILITY(U,$J,358.3,28861,2)
 ;;=^322067
 ;;^UTILITY(U,$J,358.3,28862,0)
 ;;=233.1^^161^1805^12
 ;;^UTILITY(U,$J,358.3,28862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28862,1,3,0)
 ;;=3^233.1
 ;;^UTILITY(U,$J,358.3,28862,1,4,0)
 ;;=4^CA in Situ (Sev. Dysplasia)
 ;;^UTILITY(U,$J,358.3,28862,2)
 ;;=^267736
 ;;^UTILITY(U,$J,358.3,28863,0)
 ;;=795.01^^161^1805^4
 ;;^UTILITY(U,$J,358.3,28863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28863,1,3,0)
 ;;=3^795.01
 ;;^UTILITY(U,$J,358.3,28863,1,4,0)
 ;;=4^Abnormal Pap-ASC-US
 ;;^UTILITY(U,$J,358.3,28863,2)
 ;;=^331972
 ;;^UTILITY(U,$J,358.3,28864,0)
 ;;=795.02^^161^1805^3
 ;;^UTILITY(U,$J,358.3,28864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28864,1,3,0)
 ;;=3^795.02
 ;;^UTILITY(U,$J,358.3,28864,1,4,0)
 ;;=4^Abnormal Pap-ASC-H
 ;;^UTILITY(U,$J,358.3,28864,2)
 ;;=^331973
 ;;^UTILITY(U,$J,358.3,28865,0)
 ;;=795.03^^161^1805^6
 ;;^UTILITY(U,$J,358.3,28865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28865,1,3,0)
 ;;=3^795.03
 ;;^UTILITY(U,$J,358.3,28865,1,4,0)
 ;;=4^Abnormal Pap-LGSIL
 ;;^UTILITY(U,$J,358.3,28865,2)
 ;;=^331571
 ;;^UTILITY(U,$J,358.3,28866,0)
 ;;=795.04^^161^1805^5
 ;;^UTILITY(U,$J,358.3,28866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28866,1,3,0)
 ;;=3^795.04
 ;;^UTILITY(U,$J,358.3,28866,1,4,0)
 ;;=4^Abnormal Pap-HGSIL
 ;;^UTILITY(U,$J,358.3,28866,2)
 ;;=^331572
 ;;^UTILITY(U,$J,358.3,28867,0)
 ;;=795.05^^161^1805^13
 ;;^UTILITY(U,$J,358.3,28867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28867,1,3,0)
 ;;=3^795.05
 ;;^UTILITY(U,$J,358.3,28867,1,4,0)
 ;;=4^Cervical High Risk HPV
 ;;^UTILITY(U,$J,358.3,28867,2)
 ;;=^331573
 ;;^UTILITY(U,$J,358.3,28868,0)
 ;;=795.06^^161^1805^33
 ;;^UTILITY(U,$J,358.3,28868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28868,1,3,0)
 ;;=3^795.06
 ;;^UTILITY(U,$J,358.3,28868,1,4,0)
 ;;=4^Pap w/Cyto Evidence of Malig
 ;;^UTILITY(U,$J,358.3,28868,2)
 ;;=^334169
 ;;^UTILITY(U,$J,358.3,28869,0)
 ;;=078.11^^161^1805^15
 ;;^UTILITY(U,$J,358.3,28869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28869,1,3,0)
 ;;=3^078.11
 ;;^UTILITY(U,$J,358.3,28869,1,4,0)
 ;;=4^Condyloma
 ;;^UTILITY(U,$J,358.3,28869,2)
 ;;=^295788
 ;;^UTILITY(U,$J,358.3,28870,0)
 ;;=V25.41^^161^1805^40
 ;;^UTILITY(U,$J,358.3,28870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28870,1,3,0)
 ;;=3^V25.41
 ;;^UTILITY(U,$J,358.3,28870,1,4,0)
 ;;=4^Surveillance Contracept Pill 
 ;;^UTILITY(U,$J,358.3,28870,2)
 ;;=^295349
 ;;^UTILITY(U,$J,358.3,28871,0)
 ;;=V25.42^^161^1805^41
 ;;^UTILITY(U,$J,358.3,28871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28871,1,3,0)
 ;;=3^V25.42
 ;;^UTILITY(U,$J,358.3,28871,1,4,0)
 ;;=4^Surveillance IUD
 ;;^UTILITY(U,$J,358.3,28871,2)
 ;;=^295350
 ;;^UTILITY(U,$J,358.3,28872,0)
 ;;=V25.43^^161^1805^43
 ;;^UTILITY(U,$J,358.3,28872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28872,1,3,0)
 ;;=3^V25.43
 ;;^UTILITY(U,$J,358.3,28872,1,4,0)
 ;;=4^Surveillance Subdermal Contracept
 ;;^UTILITY(U,$J,358.3,28872,2)
 ;;=^295351
 ;;^UTILITY(U,$J,358.3,28873,0)
 ;;=V25.49^^161^1805^42
 ;;^UTILITY(U,$J,358.3,28873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28873,1,3,0)
 ;;=3^V25.49
 ;;^UTILITY(U,$J,358.3,28873,1,4,0)
 ;;=4^Surveillance Other Method
 ;;^UTILITY(U,$J,358.3,28873,2)
 ;;=^276535
 ;;^UTILITY(U,$J,358.3,28874,0)
 ;;=V87.39^^161^1806^1
 ;;^UTILITY(U,$J,358.3,28874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28874,1,3,0)
 ;;=3^V87.39
 ;;^UTILITY(U,$J,358.3,28874,1,4,0)
 ;;=4^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,28874,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,28875,0)
 ;;=V03.1^^161^1807^24
 ;;^UTILITY(U,$J,358.3,28875,1,0)
 ;;=^358.31IA^4^2
